• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合光动力疗法与局部应用贝伐单抗治疗对兔角膜新生血管的影响

Effects of Combined Photodynamic Therapy and Topical Bevacizumab Treatment on Corneal Neovascularization in Rabbits.

作者信息

Kim Rae Young, Chung Sung Kun, Kim Man Soo, Ra Ho

机构信息

Department of Ophthalmology and Visual Science, College of Medicine, The Catholic University of Korea, Seoul, South Korea.

出版信息

Cornea. 2016 Dec;35(12):1615-1620. doi: 10.1097/ICO.0000000000001016.

DOI:10.1097/ICO.0000000000001016
PMID:27684458
Abstract

PURPOSE

To evaluate the effects of combined photodynamic therapy (PDT) and topical bevacizumab treatment on corneal neovascularization in rabbits.

METHODS

Corneal neovascularization was induced by placing a suture for 7 days in both eyes of 15 rabbits. After suture removal, the right eyes of the rabbits were divided into 3 treatment groups (n = 5 each): group 1, 5 mg/mL bevacizumab eye drops; group 2, PDT at 150 J/cm; and group 3, combined PDT and topical bevacizumab treatment. All 15 left eyes formed a control group. After 2 weeks of treatment, digital photographs were obtained and analyzed to determine the area of corneal neovascularization. The rabbits were then killed to measure vascular endothelial growth factor (VEGF) levels in corneal tissues.

RESULTS

The corneal neovascularization area after treatment was significantly smaller in the 3 treatment groups compared with that in the control group. A significant difference was observed between groups 1 and 2 and group 3, but not between groups 1 and 2. VEGF levels were significantly lower in groups 1 and 3 than in the control group. Although group 2 exhibited relatively higher VEGF levels compared with the control group, the difference was not significant.

CONCLUSIONS

Our results suggest that combined PDT and topical bevacizumab treatment is significantly more effective than monotherapy for the treatment of corneal neovascularization in rabbits. Such quantitative comparison in the laboratory is believed to provide the theoretical basis for clinical application of combined PDT and topical bevacizumab treatment.

摘要

目的

评估光动力疗法(PDT)联合局部应用贝伐单抗治疗对兔角膜新生血管化的影响。

方法

对15只兔双眼放置缝线7天诱导角膜新生血管化。拆线后,将兔右眼分为3个治疗组(每组n = 5):第1组,5 mg/mL贝伐单抗滴眼液;第2组,150 J/cm的PDT;第3组,PDT联合局部应用贝伐单抗治疗。所有15只左眼形成对照组。治疗2周后,获取数码照片并分析以确定角膜新生血管化面积。然后处死兔以测量角膜组织中血管内皮生长因子(VEGF)水平。

结果

与对照组相比,3个治疗组治疗后的角膜新生血管化面积明显更小。第1组与第2组和第3组之间观察到显著差异,但第1组和第2组之间无显著差异。第1组和第3组的VEGF水平明显低于对照组。虽然第2组与对照组相比VEGF水平相对较高,但差异不显著。

结论

我们的结果表明,PDT联合局部应用贝伐单抗治疗在治疗兔角膜新生血管化方面明显比单一疗法更有效。实验室中的这种定量比较被认为可为PDT联合局部应用贝伐单抗治疗的临床应用提供理论依据。

相似文献

1
Effects of Combined Photodynamic Therapy and Topical Bevacizumab Treatment on Corneal Neovascularization in Rabbits.联合光动力疗法与局部应用贝伐单抗治疗对兔角膜新生血管的影响
Cornea. 2016 Dec;35(12):1615-1620. doi: 10.1097/ICO.0000000000001016.
2
[Corneal neovascularisation treatments compared: Subconjunctival bevacizumab injections and/or photodynamic therapy].[角膜新生血管化治疗对比:结膜下注射贝伐单抗和/或光动力疗法]
J Fr Ophtalmol. 2015 Dec;38(10):924-33. doi: 10.1016/j.jfo.2015.06.006. Epub 2015 Oct 29.
3
Inhibitory Effect of Topical Aflibercept on Corneal Neovascularization in Rabbits.局部注射阿柏西普对兔角膜新生血管的抑制作用
Cornea. 2015 Oct;34(10):1303-7. doi: 10.1097/ICO.0000000000000507.
4
The effect of subconjuctival combined treatment of bevacizumab and triamcinolone acetonide on corneal neovascularization in rabbits.贝伐单抗联合曲安奈德对兔角膜新生血管的作用。
Cornea. 2010 Feb;29(2):192-6. doi: 10.1097/ICO.0b013e3181b1c82f.
5
Comparative study of tacrolimus and bevacizumab on corneal neovascularization in rabbits.他克莫司与贝伐单抗对兔角膜新生血管化的比较研究。
Cornea. 2015 Apr;34(4):449-55. doi: 10.1097/ICO.0000000000000336.
6
Effects of subconjunctival tocilizumab versus bevacizumab in treatment of corneal neovascularization in rabbits.结膜下注射托珠单抗与贝伐单抗治疗兔角膜新生血管的效果比较
Cornea. 2014 Oct;33(10):1088-94. doi: 10.1097/ICO.0000000000000220.
7
Inhibition of corneal neovascularization by topical bevacizumab (Anti-VEGF) and Sunitinib (Anti-VEGF and Anti-PDGF) in an animal model.在动物模型中,局部应用贝伐单抗(抗 VEGF)和舒尼替尼(抗 VEGF 和抗 PDGF)抑制角膜新生血管形成。
Am J Ophthalmol. 2010 Oct;150(4):519-528.e1. doi: 10.1016/j.ajo.2010.04.024. Epub 2010 Jun 29.
8
Comparison of photodynamic therapy with two different parameters combined with subconjunctival injection of bevacizumab for corneal neovascularization.光动力疗法联合两种不同参数与结膜下注射贝伐单抗治疗角膜新生血管的比较。
Photodiagnosis Photodyn Ther. 2024 Apr;46:104067. doi: 10.1016/j.pdpdt.2024.104067. Epub 2024 Mar 26.
9
Photodynamic therapy with verteporfin combined with subconjunctival injection of bevacizumab for corneal neovascularization.光动力疗法联合贝伐单抗球结膜下注射治疗角膜新生血管。
Cornea. 2011 Jan;30(1):30-3. doi: 10.1097/ICO.0b013e3181dc81a0.
10
Comparison of Topical Pigment Epithelium-Derived Factor (PEDF) with Topical Bevacizumab for Accelerating the Regression of Corneal Neovascularization in an Experimental Model of Rabbit Corneal Angiogenesis.比较局部色素上皮衍生因子(PEDF)与局部贝伐单抗对兔角膜血管生成实验模型中角膜新生血管消退的作用。
Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1471-1477. doi: 10.1080/09273948.2020.1751211. Epub 2020 May 14.

引用本文的文献

1
Management of corneal neovascularization: Current and emerging therapeutic approaches.角膜新生血管的治疗管理:当前和新兴的治疗方法。
Indian J Ophthalmol. 2024 May 1;72(Suppl 3):S354-S371. doi: 10.4103/IJO.IJO_3043_23. Epub 2024 Apr 20.
2
Minocycline-loaded nHAP/PLGA microspheres for prevention of injury-related corneal angiogenesis.载米诺环素的 nHAP/PLGA 微球用于预防损伤相关性角膜血管生成。
J Nanobiotechnology. 2024 Mar 28;22(1):134. doi: 10.1186/s12951-024-02317-7.
3
Rhamnazin attenuates inflammation and inhibits alkali burn-induced corneal neovascularization in rats.
鼠李素可减轻炎症并抑制大鼠碱烧伤诱导的角膜新生血管形成。
RSC Adv. 2018 Jul 27;8(47):26696-26706. doi: 10.1039/c8ra03159b. eCollection 2018 Jul 24.
4
Photo-Mediated Ultrasound Therapy for the Treatment of Corneal Neovascularization in Rabbit Eyes.光介导超声治疗兔眼角膜新生血管。
Transl Vis Sci Technol. 2020 Dec 9;9(13):16. doi: 10.1167/tvst.9.13.16. eCollection 2020 Dec.
5
Lipid Keratopathy: A Review of Pathophysiology, Differential Diagnosis, and Management.脂质角膜病变:病理生理学、鉴别诊断及治疗综述
Ophthalmol Ther. 2020 Dec;9(4):833-852. doi: 10.1007/s40123-020-00309-y. Epub 2020 Oct 15.
6
Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1.异甘草素通过抑制 COX-2、mPGES-1 和 CYP4A 阻断 miR-194-5p 和 lncRNA NEAT1 的 ceRNA 效应抑制胶质瘤中的血管生成 Akt 信号。
J Exp Clin Cancer Res. 2019 Aug 22;38(1):371. doi: 10.1186/s13046-019-1361-2.
7
Effectiveness of photodynamic therapy with verteporfin combined with intrastromal bevacizumab for corneal neovascularization in Stevens-Johnson syndrome.维替泊芬光动力疗法联合基质内注射贝伐单抗治疗史蒂文斯-约翰逊综合征角膜新生血管的疗效
Int Ophthalmol. 2019 Jan;39(1):55-62. doi: 10.1007/s10792-017-0786-x. Epub 2017 Dec 18.
8
Therapeutic approaches for corneal neovascularization.角膜新生血管的治疗方法。
Eye Vis (Lond). 2017 Dec 10;4:28. doi: 10.1186/s40662-017-0094-6. eCollection 2017.